Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-21-001295
Filing Date
2021-01-26
Accepted
2021-01-26 17:01:29
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 govx20210122_s3.htm S-3 356345
2 EXHIBIT 5.1 ex_222556.htm EX-5.1 21728
3 EXHIBIT 23.1 ex_222561.htm EX-23.1 3445
4 EXHIBIT 23.2 ex_222562.htm EX-23.2 3466
5 ex_222556img001.jpg GRAPHIC 6688
6 ex_222556img002.jpg GRAPHIC 2122
7 ex_222556img003.jpg GRAPHIC 7911
8 govx20210122_s3img001.jpg GRAPHIC 7891
9 govx20210122_s3img002.jpg GRAPHIC 8956
10 govx20210122_s3img003.gif GRAPHIC 13890
  Complete submission text file 0001437749-21-001295.txt   452424
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-252437 | Film No.: 21554892
SIC: 2834 Pharmaceutical Preparations